Table 1. Baseline data.
| n = 102 | |
|---|---|
| Age [years] | 60.8±8.9 |
| Sex, female | 18 (17.6%) |
| BMI [kg/m2] | 26.8±4.0 |
| BSA [m2] | 2.02±0.21 |
| Type AF | |
| Paroxysmal | 73 (71.6%) |
| Persistent | 29 (28.4%) |
| CV risk factors | |
| Arterial hypertension | 55 (53.9%) |
| Heart failure | 7 (6.9%) |
| Diabetes | 7 (6.9%) |
| Renal failure | 8 (7.8%) |
| Myocardial infarction | 3 (2.9%) |
| Stroke | 7 (6.9%) |
| Smoking status | |
| Never | 41 (40.2%) |
| Active | 11 (10.8%) |
| Former | 50 (49.0%) |
| CHA2DS2VASc | |
| 0 | 23 (22.5%) |
| 1 | 31 (30.4%) |
| 2 | 29 (28.4%) |
| 3 | 11 (10.8%) |
| 4 | 6 (5.9%) |
| 5 | 1 (1.0%) |
| 6 | 0 |
| CHA2DS2VASc | |
| Low stroke risk (CHA2DS2VASc ≤ 1) | 55 (53.9%) |
| Increased stroke risk (CHA2DS2VASc ≥ 2) | 47 (46.1%) |
| EHRA score | |
| I | 8 (8%) |
| II | 57 (56%) |
| III | 30 (29%) |
| IV | 1 (1%) |
| AF Burden score (AFBS) | |
| 1 | 8 (7.8%) |
| 2 | 65 (63.7%) |
| 3 | 23 (22.5%) |
| 4 | 5 (4.9%) |
| LA parameters | |
| LAV_max [ml] | 102.5±34.2 |
| LAV_min [ml] | 54.3±28.8 |
| LAV_preA [ml] | 80.8±30.9 |
| LAV_min2 [ml] | 76.3±30.5 |
| LAVi_max [ml/m2] | 50.9 ± 16.1 |
| LAVi_min [ml/m2] | 27.0 ± 14.3 |
| LAVi_preA [ml/m2] | 40.1±14.7 |
| LAVi_min2 [ml/m2] | 37.9±14.8 |
| LAEF_total [%] | 48.6±12.1 |
| LAEF_active [%] | 35.2±12.2 |
| LAEF_passive [%] | 21.7±7.9 |
| LVEF [%] | 57.4±8.0 |